Mankind Pharma

Please find attached intimation of payment of interest and redemption amount to the NCD holders of the Company.

16 Apr, 2026 | 04:47pm • Source: BSE

Board of Directors of the Company in its meeting held on April 13, 2026 i.e. today, approved the closure/winding up of Mankind Pharma Lanka (Private)...

13 Apr, 2026 | 03:29pm • Source: BSE

Please find attached outcome of board meeting held on April 13, 2026

13 Apr, 2026 | 03:26pm • Source: BSE

Please find attached certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

06 Apr, 2026 | 03:13pm • Source: BSE

Intimation of closure of trading window

27 Mar, 2026 | 11:20am • Source: BSE

Mankind Pharma Limited has informed the Exchange regarding a press release dated March 18, 2026, titled "Mankind Pharma acquires Rivotril brand for India, reinforcing focus...

18 Mar, 2026 | 10:54am • Source: NSE

Please find attached press release titled "Mankind Pharma acquires Rivotril brand for India, reinforcing focus on chronic CNS therapies".

18 Mar, 2026 | 10:02am • Source: BSE

Please find attached intimation regarding allotment of 23,256 equity shares pursuant to Mankind Employee Stock Option Plan 2022.

16 Mar, 2026 | 01:45pm • Source: BSE

The Exchange has sought clarification from Mankind Pharma Ltd on February 27, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.

27 Feb, 2026 | 11:58am • Source: BSE

Please find attached intimation under Regulation 30 of SEBI LODR Regulations, 2015

26 Feb, 2026 | 06:24pm • Source: BSE

Intimation regarding reaffirmaiton of Credit Ratings

24 Feb, 2026 | 06:20pm • Source: BSE

Please find attached intimation of participation in Investor Conference

18 Feb, 2026 | 03:03pm • Source: BSE

Please find attached disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

16 Feb, 2026 | 06:49pm • Source: BSE

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

09 Feb, 2026 | 03:01pm • Source: BSE

Please find enclosed herewith the transcript of the investor conference call for Q3 & 9M FY26 held on February 3, 2026.

09 Feb, 2026 | 01:37pm • Source: BSE

Please find attached intimation regarding newspaper advertisement - Unaudited Financial Results of the Company for Q3 FY26

04 Feb, 2026 | 02:09pm • Source: BSE

Please find attached intimation of participation in Investor Conference

04 Feb, 2026 | 01:45pm • Source: BSE

Please find attached intimation containing link of the Audio Recording-Investor Conference Call for Q3 & 9M FY26

03 Feb, 2026 | 09:53pm • Source: BSE

Compliance Certificate under Regulation 54 of SEBI LODR for Q3 FY26

03 Feb, 2026 | 04:25pm • Source: BSE

Investor Presentation of Q3 FY26 for financial results

03 Feb, 2026 | 04:21pm • Source: BSE